AshokChauhanMD
Pulmonology • Arlington, VACritical Care Medicine, Interventional Pulmonology, Pleural Disease
Physician
Are you Dr. Chauhan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
611 S Carlin Springs Rd
Ste 511
Arlington, VA 22204Phone+1 703-379-4446Fax+1 703-379-0449
Summary
- Dr. Ashok Chauhan, MD is a pulmonologist in Arlington, Virginia. He is currently licensed to practice medicine in Virginia, District of Columbia, and Maryland. He is affiliated with Inova Alexandria Hospital and Inova Loudoun Hospital.
Education & Training
University Saskatchewan Royal HospitalPulmonary Disease, 1992 - 1994- Providence HospitalResidency, Internal Medicine, 1989 - 1992
Delhi University College of Medical SciencesClass of 1985
Certifications & Licensure
DC State Medical License 1995 - Present
VA State Medical License 1994 - 2026
MD State Medical License 1991 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 8 citationsChimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection.Shalmali Bivalkar-Mehla, Rajeev Mehla, Ashok Chauhan
Journal of Drug Targeting. 2017-04-21 - 31 citationsNeuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.Maria Podbielska, Arabinda Das, Amena W. Smith, Ashok Chauhan, Swapan K. Ray
Journal of Neurochemistry. 2016-10-18 - 24 citationsEnigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agentAshok Chauhan
Microbes and Infection. 2015-09-01
Press Mentions
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s DiseaseMarch 2nd, 2021
Preparation and Characterization of Nanocurcumin Based Hybrid Virosomes as a Drug Delivery Vehicle with Enhanced Anticancerous Activity and Reduced ToxicityJanuary 11th, 2021- Preparation and Characterization of Nanocurcumin Based Hybrid Virosomes as a Drug Delivery Vehicle with Enhanced Anticancerous Activity and Reduced ToxicityJanuary 11th, 2021
- Join now to see all
Professional Memberships
- Member
